Search Prime Grants

U01CA250040

Cooperative Agreement

Overview

Grant Description
Exploiting the mechanobiology of PD-1 for cancer immunotherapy.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Place of Performance
Atlanta, Georgia 303320420 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 438% from $656,845 to $3,532,601.
Georgia Tech Research was awarded Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy Cooperative Agreement U01CA250040 worth $3,532,601 from National Cancer Institute in June 2020 with work to be completed primarily in Atlanta Georgia United States. The grant has a duration of 5 years and was awarded through assistance program 93.396 Cancer Biology Research. The Cooperative Agreement was awarded through grant opportunity Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional).

Status
(Complete)

Last Modified 7/19/24

Period of Performance
6/1/20
Start Date
5/31/25
End Date
100% Complete

Funding Split
$3.5M
Federal Obligation
$0.0
Non-Federal Obligation
$3.5M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U01CA250040

Subgrant Awards

Disclosed subgrants for U01CA250040

Transaction History

Modifications to U01CA250040

Additional Detail

Award ID FAIN
U01CA250040
SAI Number
U01CA250040-1024968654
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
EMW9FC8J3HN4
Awardee CAGE
1G474
Performance District
GA-05
Senators
Jon Ossoff
Raphael Warnock

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $2,134,942 100%
Modified: 7/19/24